Posts

Why Hanmi’s Deals With Genentech and Eli Lilly Matter Beyond Korea’s Drug Industry

A Korean Hospital’s AI Blood Test Points to a Less Invasive Future for Colon Cancer Screening — and Raises Big Questions for the U.S.

South Korea’s biotech surge is no longer a one-company story — and the U.S. has reason to pay attention

A South Korean Drugmaker’s Profit Surge Offers a Rare, Concrete Test of Whether a New Medicine Can Become a Real Business

A Korean Drugmaker Says Its New Gout Treatment Beat a Standard Therapy in Late-Stage Asian Trial

South Korea’s Trade Agency Broadens Its Export Playbook, Looking Beyond K-pop and Semiconductors